Singapore markets close in 6 hours 7 minutes
Straits Times Index
3,355.64 +17.07 (+0.51%) Nikkei
39,780.58 +149.52 (+0.38%) Hang Seng
17,888.33 +169.72 (+0.96%) FTSE 100
8,166.76 +2.64 (+0.03%) Bitcoin USD
62,922.30 -381.82 (-0.60%) CMC Crypto 200
1,344.62 +42.54 (+3.27%)
Rohto Pharmaceutical Co.,Ltd. (4527.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
As of 11:30AM JST. Market open.
| Previous close | 3,348.00 |
| Open | 3,321.00 |
| Bid | 3,314.00 x 0 |
| Ask | 3,318.00 x 0 |
| Day's range | 3,294.00 - 3,340.00 |
| 52-week range | 2,640.50 - 4,117.00 |
| Volume | |
| Avg. volume | 938,227 |
| Market cap | 756.737B |
| Beta (5Y monthly) | -0.14 |
| PE ratio (TTM) | 24.52 |
| EPS (TTM) | 135.26 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 30.00 (0.90%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | 3,993.00 |
- Reuters SG
Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and founding family members of Eu Yan Sang, according to a separate statement issued by Tower Capital Asia on Thursday.
© 2024 Yahoo. All rights reserved.